Yoh K - Search Results

1

Impact of Maintenance Therapy for Patients with Non-small Cell Lung Cancer in a Real-world Setting.

Yoh K, Goto Y, Naito Y, Kishi K, Mori K, Hotta K, Hosomi Y, Yamada K, Tanai C, Tomizawa Y, Inoue A, Hasegawa Y, Nishio M, Ohashi Y, Kunitoh H. Yoh K, et al. Anticancer Res. 2017 Mar;37(3):1507-1513. doi: 10.21873/anticanres.11478. Anticancer Res. 2017. PMID: 28314326

2

A phase I study of combination chemotherapy with gemcitabine and oral UFT for advanced non-small cell lung cancer.

Seto T, Yoh K, Asoh H, Yamamoto H, Semba H, Ichinose Y. Seto T, et al. Among authors: yoh k. Br J Cancer. 2002 Jun 5;86(11):1701-4. doi: 10.1038/sj.bjc.6600337. Br J Cancer. 2002. PMID: 12087453 Free PMC article. Clinical Trial.

3

[New treatment strategy for stage III non-small-cell lung cancer].

Yoh K, Kubota K. Yoh K, et al. Nihon Rinsho. 2002 May;60 Suppl 5:485-9. Nihon Rinsho. 2002. PMID: 12101719 Review. Japanese. No abstract available.

4

Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer.

Yoh K, Ishii G, Yokose T, Minegishi Y, Tsuta K, Goto K, Nishiwaki Y, Kodama T, Suga M, Ochiai A. Yoh K, et al. Clin Cancer Res. 2004 Mar 1;10(5):1691-7. doi: 10.1158/1078-0432.ccr-0937-3. Clin Cancer Res. 2004. PMID: 15014021

5

First-line single agent treatment with gefitinib in patients with advanced non-small-cell lung cancer: a phase II study.

Niho S, Kubota K, Goto K, Yoh K, Ohmatsu H, Kakinuma R, Saijo N, Nishiwaki Y. Niho S, et al. Among authors: yoh k. J Clin Oncol. 2006 Jan 1;24(1):64-9. doi: 10.1200/JCO.2005.02.5825. J Clin Oncol. 2006. PMID: 16382114 Clinical Trial.

6

Eg5 expression is closely correlated with the response of advanced non-small cell lung cancer to antimitotic agents combined with platinum chemotherapy.

Saijo T, Ishii G, Ochiai A, Yoh K, Goto K, Nagai K, Kato H, Nishiwaki Y, Saijo N. Saijo T, et al. Among authors: yoh k. Lung Cancer. 2006 Nov;54(2):217-25. doi: 10.1016/j.lungcan.2006.06.018. Epub 2006 Aug 24. Lung Cancer. 2006. PMID: 16934364

7

Phase II trial of carboplatin and paclitaxel in non-small cell lung cancer patients previously treated with chemotherapy.

Yoh K, Kubota K, Kakinuma R, Ohmatsu H, Goto K, Niho S, Saijo N, Nishiwaki Y. Yoh K, et al. Lung Cancer. 2007 Oct;58(1):73-9. doi: 10.1016/j.lungcan.2007.04.015. Epub 2007 Jun 4. Lung Cancer. 2007. PMID: 17548127 Clinical Trial.

8

Concurrent chemoradiotherapy with cisplatin and vinorelbine for stage III non-small cell lung cancer.

Naito Y, Kubota K, Nihei K, Fujii T, Yoh K, Niho S, Goto K, Ohmatsu H, Saijo N, Nishiwaki Y. Naito Y, et al. Among authors: yoh k. J Thorac Oncol. 2008 Jun;3(6):617-22. doi: 10.1097/JTO.0b013e3181753b38. J Thorac Oncol. 2008. PMID: 18520801 Free article. Clinical Trial.

9

Clinical outcome of chemoradiation therapy in patients with limited-disease small cell lung cancer with ipsilateral pleural effusion.

Niho S, Kubota K, Yoh K, Goto K, Ohmatsu H, Nihei K, Saijo N, Nishiwaki Y. Niho S, et al. Among authors: yoh k. J Thorac Oncol. 2008 Jul;3(7):723-7. doi: 10.1097/JTO.0b013e31817c606a. J Thorac Oncol. 2008. PMID: 18594317 Free article.

10

Performance status and sensitivity to first-line chemotherapy are significant prognostic factors in patients with recurrent small cell lung cancer receiving second-line chemotherapy.

Kim YH, Goto K, Yoh K, Niho S, Ohmatsu H, Kubota K, Saijo N, Nishiwaki Y. Kim YH, et al. Among authors: yoh k. Cancer. 2008 Nov 1;113(9):2518-23. doi: 10.1002/cncr.23871. Cancer. 2008. PMID: 18780323 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

417 results

Search Page

Filters